Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands

Area of Science:

• Molecular Biology
• Parasitology
• Antimicrobial Drug Discovery

Background:

• Malarial parasite (Plasmodium falciparum) DNA exhibits higher AT content compared to mammalian host cells.
• Targeting DNA structure offers a potential avenue for selective antiparasitic drug development.

Purpose of the Study:

• To investigate the selective toxicity of AT-specific DNA minor groove binders against Plasmodium falciparum.
• To explore the role of DNA base composition in the selective toxicity of these compounds.

Main Methods:

• Culturing Plasmodium falciparum and Saccharomyces cerevisiae under various conditions.
• Assessing the growth inhibition and toxicity of AT-specific minor groove binders (distamycin A, netropsin, DAPI, Hoechst 33258) and GC-specific binders (chromomycin A3, mithramycin A).
• Evaluating drug toxicity in both parasite/yeast cells and mammalian cells.

Main Results:

• AT-specific minor groove binders demonstrated significant toxicity to Plasmodium falciparum, inhibiting nucleic acid and protein synthesis.
• These compounds were more toxic to parasites than to mammalian cells, with distamycin A showing higher toxicity to ring stages.
• Selective toxicity was also observed in Saccharomyces cerevisiae, correlating with AT-rich mitochondrial DNA.

Conclusions:

• The differential DNA base composition between parasites and hosts can be exploited for selective toxicity of minor groove binders.
• AT-rich DNA is a key determinant for the selective antiparasitic activity of compounds like distamycin A, DAPI, and Hoechst 33258.
• Minor groove binders represent a promising class of compounds for developing novel antimalarial and antimicrobial therapies.